Skip to main content

Pro00113649_R668-EGE-2213: A PHASE 2/3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC GASTRITIS WITH OR WITHOUT EOSINOPHILIC DUODENITIS

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

February 29, 2024

End Date

January 31, 2026
 

Administered By

Medicine, Gastroenterology

Awarded By

Regeneron Pharmaceuticals, Inc.

Start Date

February 29, 2024

End Date

January 31, 2026